Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 30, 2018 - Issue 5
297
Views
3
CrossRef citations to date
0
Altmetric
Articles

Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people

, , , , , , & show all
Pages 643-649 | Received 12 Sep 2017, Accepted 17 Jan 2018, Published online: 28 Jan 2018

References

  • Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994). Screening for depression in well older adults: Evaluation of a short form of the CES-D (center for epidemiologic studies depression scale). American Journal of Preventive Medicine, 10(2), 77–84. doi: 10.1016/S0749-3797(18)30622-6
  • Bengtson, A. M., Pence, B. W., O’Donnell, J., Thielman, N., Heine, A., Zinski, A., & Gaynes, B. (2015). Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care, 27(1), 47–53. doi: 10.1080/09540121.2014.946386
  • Benhamou, Y., Di Martino, V., Bochet, M., Colombet, G., Thibault, V., Liou, A., & Poynard, T. (2001). Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy. Hepatology (Baltimore, Maryland.), 34(2), 283–287. doi: 10.1053/jhep.2001.26517
  • Carpenter, C. C., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., & Volberding, P. A. (1998). Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the international AIDS society-USA panel. Jama, 280(1), 78–86. doi: 10.1001/jama.280.1.78
  • Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the outcomes committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266. doi: 10.1080/09540120050042891
  • Choi, S. K., Boyle, E., Cairney, J., Collins, E. J., Gardner, S., Bacon, J., & Rourke, S. B. (2016). Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: Results from the Ontario HIV treatment network cohort study. PLoS One, 11(11), e0165816. doi: 10.1371/journal.pone.0165816
  • Cox, J., & Hamelin, A. M. (2013). Prospective investigation of the relationship between food insecurity and health and behavioural outcomes in HIV-HCV co-infection: Clues for prevention interventions (ctn 264). A Food Security & HIV-HCV Sub-Study of the Canadian Co-infection Cohort (ctn 222). Retrieved from http://www.cocostudy.ca/view-associated-studies/?ptype=22food-security22
  • DHHS. (2016). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Retrieved from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
  • Fialho, R., Pereira, M., Rusted, J., & Whale, R. (2017). Depression in HIV and HCV co-infected patients: A systematic review and meta-analysis. Psychology, Health & Medicine, 1–16. doi: 10.1080/13548506.2017.1280177
  • Forton, D. M., Taylor-Robinson, S. D., & Thomas, H. C. (2006). Central nervous system changes in hepatitis C virus infection. European Journal of Gastroenterology & Hepatology, 18(4), 333–338. doi: 10.1097/00042737-200604000-00005
  • Glass, T. R., Sterne, J. A., Schneider, M. P., De Geest, S., Nicca, D., Furrer, H., & Bucher, H. C. (2015). Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. AIDS (London, England), 29(16), 2195–2200. doi: 10.1097/qad.0000000000000782
  • Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes (1999), 58(2), 181–187. doi: 10.1097/QAI.0b013e31822d490a
  • Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S., Schooley, R. T., Jacobsen, D. M., & Volberding, P. A. (2006). Treatment for adult HIV infection: 2006 recommendations of the international AIDS society-USA panel. Jama, 296(7), 827–843. doi: 10.1001/jama.296.7.827
  • Havlir, D. V., Bassett, R., Levitan, D., Gilbert, P., Tebas, P., Collier, A. C., & Wong, J. K. (2001). Prevalence and predictive value of intermittent viremia with combination hiv therapy. Jama, 286(2), 171–179. doi: 10.1001/jama.286.2.171
  • Heaphy, E. L., Loue, S., Sajatovic, M., & Tisch, D. J. (2010). Impact of psychiatric and social characteristics on HIV sexual risk behavior in Puerto Rican women with severe mental illness. Social Psychiatry and Psychiatric Epidemiology, 45(11), 1043–1054. doi: 10.1007/s00127-009-0146-x
  • Henrich, T. J., Lauder, N., Desai, M. M., & Sofair, A. N. (2008). Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics. Journal of Community Health, 33(2), 69–77. doi: 10.1007/s10900-007-9069-1
  • Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373(6510), 123–126. doi: 10.1038/373123a0
  • Hull, M., Shafran, S., Wong, A., Tseng, A., Giguere, P., Barrett, L., & Cooper, C. (2016). CIHR Canadian HIV trials network coinfection and concurrent diseases core research group: 2016 updated Canadian HIV/Hepatitis C Adult Guidelines for management and treatment. Canadian Journal of Infectious Diseases and Medical Microbiology, 4385643. doi: 10.1155/2016/4385643
  • Ironson, G., O’Cleirigh, C., Fletcher, M. A., Laurenceau, J. P., Balbin, E., Klimas, N., & Solomon, G. (2005). Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosomatic Medicine, 67(6), 1013–1021. doi: 10.1097/01.psy.0000188569.58998.c8
  • Kaharuza, F. M., Bunnell, R., Moss, S., Purcell, D. W., Bikaako-Kajura, W., Wamai, N., & Mermin, J. (2006). Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS and Behavior, 10(4 Suppl), 105–111. doi: 10.1007/s10461-006-9142-2
  • Kim, H. N., Nance, R., Van Rompaey, S., Delaney, J. C., Crane, H. M., Cachay, E. R., & Kitahata, M. M. (2016). Poorly controlled HIV infection: An independent risk factor for liver fibrosis. Journal of Acquired Immune Deficiency Syndromes (1999), 72(4), 437–443. doi: 10.1097/qai.0000000000000992
  • Klein, M. B., Rollet, K. C., Saeed, S., Cox, J., Potter, M., Cohen, J., & Walmsley, S. (2013). HIV and hepatitis C virus coinfection in Canada: Challenges and opportunities for reducing preventable morbidity and mortality. HIV Medicine, 14(1), 10–20. doi: 10.1111/j.1468-1293.2012.01028.x
  • Klein, M. B., Saeed, S., Yang, H., Cohen, J., Conway, B., Cooper, C., & Walmsley, S. (2010). Cohort profile: The Canadian HIV-hepatitis C co-infection cohort study. International Journal of Epidemiology, 39(5), 1162–1169. doi: 10.1093/ije/dyp297
  • Koziel, M. J., & Peters, M. G. (2007). Viral hepatitis in HIV infection. The New England Journal of Medicine, 356(14), 1445–1454. doi: 10.1056/NEJMra065142
  • Kramer, J. R., Kowalkowski, M. A., Duan, Z., & Chiao, E. Y. (2015). The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. Journal of Acquired Immune Deficiency Syndromes (1999), 68(4), 456–462. doi: 10.1097/qai.0000000000000494
  • Lohse, N., Hansen, A. B., Pedersen, G., Kronborg, G., Gerstoft, J., Sorensen, H. T., & Obel, N. (2007). Survival of persons with and without HIV infection in Denmark, 1995-2005. Annals of Internal Medicine, 146(2), 87–95. doi: 10.7326/0003-4819-146-2-200701160-00003
  • Meijerink, H., Wisaksana, R., Iskandar, S., den Heijer, M., van der Ven, A. J., Alisjahbana, B., & van Crevel, R. (2014). Injecting drug use is associated with a more rapid CD4 cell decline among treatment naive HIV-positive patients in Indonesia. Journal of the International AIDS Society, 17, 18844. doi: 10.7448/ias.17.1.18844
  • Remis, R. S. (2007). Modelling the incidence and prevalence of hepatitis c infection and its Sequelae in Canada, 2007. final report. In: Community Acquired Infections Division Centre for Communicable Diseases and Infection Control Infectious Disease and Emergency Preparedness Branch Public Health Agency of Canada. Retrieved from http://atlantique.phac.gc.ca/sti-its-surv-epi/model/pdf/model07-eng.pdf
  • Robins, J. M., Hernan, M. A., & Brumback, B. (2000). Marginal structural models and causal inference in epidemiology. Epidemiology (Cambridge, Massachusetts.), 11(5), 550–560. doi: 10.1097/00001648-200009000-00011
  • Rubin, D. B., & Schenker, N. (1991). Multiple imputation in health-care databases: An overview and some applications. Statistics in Medicine, 10(4), 585–598. doi: 10.1002/sim.4780100410
  • Sanmartin, R., de Felipe, E., Tor, J., Sanvicens, A., Barluenga, E., Martinez, E., & Tural, C. (2012). Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era. AIDS Research and Human Retroviruses, 28(10), 1235–1243. doi: 10.1089/aid.2011.0322
  • Sherman, K. E., Rouster, S. D., Chung, R. T., & Rajicic, N. (2002). Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 34(6), 831–837. doi: 10.1086/339042
  • Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P., & Lundgren, J. D. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration. Lancet (London, England), 384(9939), 241–248. doi: 10.1016/s0140-6736(14)60604-8
  • Taiwo, B., Zheng, L., Gallien, S., Matining, R. M., Kuritzkes, D. R., Wilson, C. C., & Eron, J. J., Jr. (2011). Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262). AIDS (London, England), 25(17), 2113–2122. doi: 10.1097/QAD.0b013e32834bbaa9
  • UNAIDS. (2016). Global AIDS Update. Retrieved from http://www.who.int/hiv/pub/arv/global-AIDS-update-2016_en.pdf?ua=1
  • WHO. (2017). Depression and Other Common Mental Disorders: Global Health Estimates. Geneva. Licence: CC BY-NC-SA 3.0 IGO. Retrieved from http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf?ua=1&ua=1
  • Zhang, W., O’Brien, N., Forrest, J. I., Salters, K. A., Patterson, T. L., Montaner, J. S., & Lima, V. D. (2012). Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One, 7(7), e40793. doi: 10.1371/journal.pone.0040793
  • Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706. doi: 10.1093/aje/kwh090

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.